Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

被引:54
|
作者
Wen, Shi-Rong [2 ]
Liu, Guo-Jun [2 ]
Feng, Ren-Nan [3 ]
Gong, Feng-Chao [2 ]
Zhong, Hua [2 ]
Duan, Shu-Rong [2 ]
Bi, Sheng [1 ,2 ]
机构
[1] Harbin Med Coll, Cent Lab, Affiliated Hosp 1, Harbin 150001, Peoples R China
[2] Harbin Med Coll, Dept Neurol, Affiliated Hosp 1, Harbin 150001, Peoples R China
[3] Harbin Med Coll, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin 150001, Peoples R China
关键词
Osteopontin; IL-23; Multiple sclerosis; DENDRITIC CELLS; MESSENGER-RNA; PATHOGENESIS; EXPRESSION; CORRELATE; DISEASE;
D O I
10.1016/j.jneuroim.2011.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) and interleukin-23 (IL-23) are pro-inflammatory cytokines proposed to play central roles to the development of multiple sclerosis (MS). The aim of this study was to evaluate levels of OPN, IL-23 and other inflammatory cytokines and investigate their relationships in serum and cerebrospinal fluid (CSF) in patients with MS. Fifty one MS patients and 48 patients with non-inflammatory neurological diseases (NIND) were recruited from clinic. The levels of OPN, IL-23, IL-17, IL-6, and tumor necrosis factor-alpha (TNF-alpha) in serum and CSF were determined in each participant. Compared with NIND group, MS patients had significantly elevated levels of OPN, IL-23, IL-17 and TNF-alpha in CSF, and elevated levels of IL-23, IL-17 and TNF-alpha in serum (All P<0.001). In MS patients, OPN and IL-23 were positively correlated with IL-17 (r = 0.302, P=0.019; r = 0.417, P=0.001, respectively); and IL-23 was positively correlated with EDSS (r = 0.329, P=0.019). Both OPN and IL-23 may play pivotal role in development of MS and might be specific markers and therapeutic targets for MS. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [31] Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis
    Terzi, M.
    Birinci, A.
    Cetinkaya, E.
    Onar, M. K.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (05): : 325 - 330
  • [32] Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
    Khalil, M.
    Riedlbauer, B.
    Langkammer, C.
    Enzinger, C.
    Ropele, S.
    Stojakovic, T.
    Scharnagl, H.
    Culea, V.
    Petzold, A.
    Teunissen, C. E.
    Archelos, J-J
    Fuchs, S.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1569 - 1577
  • [33] Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis
    Jiménez-Jiménez, FJ
    de Bustos, F
    Molina, JA
    de Andrés, C
    Gasalla, T
    Ortí-Pareja, M
    Zurdo, M
    Porta, J
    Castellano-Millán, F
    Arenas, J
    de Salamanca, RE
    NEUROSCIENCE LETTERS, 1998, 249 (01) : 65 - 67
  • [34] Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes
    De Riz, Milena
    Galimberti, Daniela
    Fenoglio, Chiara
    Piccio, Laura M.
    Scalabrini, Diego
    Venturelli, Eliana
    Pietroboni, Anna
    Piola, Mirko
    Naismith, Robert T.
    Parks, Becky J.
    Fumagalli, Giorgio
    Bresolin, Nereo
    Cross, Anne H.
    Scarpini, Elio
    NEUROSCIENCE LETTERS, 2010, 469 (02) : 234 - 236
  • [35] Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients
    Bartosik-Psujek, H
    Stelmasiak, Z
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (06) : 797 - 803
  • [36] Increased serum osteopontin levels in autistic children: Relation to the disease severity
    AL-ayadhi, Laila Y.
    Mostafa, Gehan A.
    BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (07) : 1393 - 1398
  • [37] Plasma osteopontin levels in multiple sclerosis
    Comabella, M
    Pericot, I
    Goertsches, R
    Nos, C
    Castillo, M
    Navarro, JB
    Río, J
    Montalban, X
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 158 (1-2) : 231 - 239
  • [38] Cerebrospinal fluid in multiple sclerosis
    Rammohan, Kottil W.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2009, 12 (04) : 246 - 253
  • [39] Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis
    Speciale, L
    Sarasella, M
    Ruzzante, S
    Caputo, D
    Mancuso, R
    Calvo, MG
    Guerini, FR
    Ferrante, P
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S62 - S66
  • [40] Increased cerebrospinal fluid tau protein in multiple sclerosis
    Kapaki, E
    Paraskevas, GP
    Michalopoulou, M
    Kilidireas, K
    EUROPEAN NEUROLOGY, 2000, 43 (04) : 228 - 232